Clinical Trial Update: Study of the PAS-Port® Proximal Anastomosis System in Coronary Bypass Surgery [Phase 3]

View source ↗

Summary

This is a completed Phase 3 clinical trial evaluating the PAS-Port Proximal Anastomosis System in coronary bypass surgery for coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• PAS-Port Proximal Anastomosis System

Snippet

Sponsor: Cardica, Inc | Conditions: Coronary Artery Disease | Phase 3 | Status: COMPLETED